← Eichor
Condition: Men1 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Men1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Phase 1/Phase 2 · 104 location(s) · Sumitomo Pharma America, Inc. · NCT04988555Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07101497The Intersection of Oncology Care and Worker Well-Being
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT05250284Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · 106 location(s) · Kura Oncology, Inc. · NCT07007312Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT06430021Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT03048266A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediat
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06448013A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax,
Phase 1 · 44 location(s) · Kura Oncology, Inc. · NCT05735184BY002 IIT Study in R/R Acute Leukemia
Phase 1 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07270770A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
Phase N/A · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07559695Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study
NA · 2 location(s) · Kocaeli University · NCT05927519A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Phase 1/Phase 2 · 102 location(s) · Janssen Research & Development, LLC · NCT04811560SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurren
Phase 1 · 4 location(s) · Uma Borate · NCT06222580Study and Follow-up of Multiple Endocrine Neoplasia Type 1
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT03348501Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With M
Phase N/A · 1 location(s) · University of Freiburg · NCT07627568Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
Phase 2/Phase 3 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT07444723Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04074135Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06540937Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
NA · 1 location(s) · Arizona State University · NCT06946017BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia
Phase 1/Phase 2 · 1 location(s) · Chen Suning · NCT06746519Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Natural History Study of Parathyroid Disorders
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT04969926Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions
Phase N/A · 1 location(s) · Herlev Hospital · NCT07272187A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patien
Phase 1 · 22 location(s) · National Cancer Institute (NCI) · NCT05886049Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Phase N/A · 3 location(s) · Universidad Nacional Autonoma de Mexico · NCT06523582Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
Phase 1 · 20 location(s) · PedAL BCU, LLC · NCT06376162A Study of Revumenib and Mezigdomide in People With Leukemia
Phase 1/Phase 2 · 10 location(s) · Memorial Sloan Kettering Cancer Center · NCT07356154A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
Phase 2 · 2 location(s) · M.D. Anderson Cancer Center · NCT06229912Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males
Phase 1/Phase 2 · 1 location(s) · YourChoice Therapeutics, Inc. · NCT06542237
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.